Sino Biological,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	407.64	233.35	1,316	2,380	2,872	56.12
Trading Asset Securities	2,854	3,716	3,533	3,422	3,638	1,073
Cash & Short-Term Investments	3,262	3,949	4,849	5,802	6,511	1,129
Cash Growth	-16.54%	-18.55%	-16.43%	-10.88%	476.77%	2067.15%
Accounts Receivable	179.95	151.44	126.33	141.08	154.07	195.49
Other Receivables	8.87	20.18	22.07	15.66	6.18	1.77
Receivables	188.82	171.63	148.4	156.74	160.25	197.27
Inventory	78.54	64.4	52.53	47.49	24.75	14.25
Prepaid Expenses	-	5.45	6.63	-	6.35	-
Other Current Assets	27.67	16.61	12.65	17.72	16.74	18.33
Total Current Assets	3,557	4,208	5,069	6,024	6,719	1,359
Property, Plant & Equipment	863.5	893.55	900.9	210.96	107.57	52.41
Long-Term Investments	321.44	229.17	215.94	180.24	-	-
Goodwill	281.66	278.38	-	-	-	-
Other Intangible Assets	41.5	44.79	0.8	1.11	0.92	0.38
Long-Term Deferred Tax Assets	113.93	113.81	104.63	80.28	38.26	46.56
Long-Term Deferred Charges	53.04	59.69	59.73	49	9.31	7.01
Other Long-Term Assets	245.94	227.74	249.64	34.64	15.34	-
Total Assets	5,478	6,055	6,601	6,580	6,890	1,465
Accounts Payable	19.56	18.21	19.33	29.23	4.25	6.89
Accrued Expenses	36.84	46.04	54.3	44.09	36.02	62.08
Current Portion of Leases	16.21	22.47	23.37	19.81	20.45	-
Current Income Taxes Payable	11.21	10.3	3.05	6.76	11.94	74.66
Current Unearned Revenue	31.2	29.85	22.74	20.71	13.81	9.36
Other Current Liabilities	12.71	70.64	13.58	4.6	11.89	7.83
Total Current Liabilities	127.74	197.52	136.38	125.2	98.37	160.82
Long-Term Leases	35.84	44.9	61.69	50.65	26.9	-
Long-Term Unearned Revenue	2.42	2.54	4.22	5.63	-	-
Long-Term Deferred Tax Liabilities	34.81	36.84	31.41	29.64	12.65	5.56
Total Liabilities	200.81	281.8	233.7	211.11	137.92	166.38
Common Stock	121.64	121.64	129.2	129.2	68	51
Additional Paid-In Capital	4,354	4,353	4,796	4,793	4,853	141.86
Retained Earnings	802.23	1,300	1,434	1,432	1,809	1,089
Comprehensive Income & Other	-0.56	-1.48	7.97	14.51	22.11	16.55
Shareholders' Equity	5,277	5,773	6,367	6,369	6,752	1,299
Total Liabilities & Equity	5,478	6,055	6,601	6,580	6,890	1,465
Total Debt	52.05	67.37	85.06	70.46	47.36	-
Net Cash (Debt)	3,210	3,882	4,764	5,732	6,463	1,129
Net Cash Growth	-16.39%	-18.51%	-16.89%	-11.32%	472.58%	2067.15%
Net Cash Per Share	25.99	30.34	36.87	50.32	60.03	11.65
Filing Date Shares Outstanding	121.64	121.64	129.2	129.2	129.2	96.9
Total Common Shares Outstanding	121.64	121.64	129.2	129.2	129.2	96.9
Working Capital	3,429	4,010	4,933	5,899	6,620	1,198
Book Value Per Share	43.38	47.46	49.28	49.30	52.26	13.40
Tangible Book Value	4,954	5,450	6,366	6,368	6,751	1,298
Tangible Book Value Per Share	40.73	44.80	49.27	49.29	52.26	13.40
Buildings	-	637.92	637.92	-	-	-
Machinery	-	300.85	268.29	200.86	105.49	88.17
Construction In Progress	-	44.49	8.55	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.